Trump said that generics imported into the US could be subject to 100% tariffs
US President Donald Trump announced steep tariffs on generic medicines from 2028, despite the products being exempt under the EU’s trade deal with Washington.
Early Wednesday, Trump posted on his Truth Social account that generics imported into the US could be subject to 100% tariffs from 1 August 2028, rising to 200% a year later.
“This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them,” he wrote.
The move comes despite the EU and US agreeing clear exemptions for cheaper, off-patent generic drugs under the trade deal struck in April, keeping them at the current 0% tariff rate. Innovative branded pharmaceuticals, meanwhile, are capped at 15%.
